Long Term Safety Throughout 18 month treatment period [clinicaltrials_resource:ffd55f1aa78e0a130612e1bd3cc07f74]

Long Term Safety Throughout 18 month treatment period [clinicaltrials_resource:ffd55f1aa78e0a130612e1bd3cc07f74]

10mg Tablet, oral Daily for 18 months
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ffd55f1aa78e0a130612e1bd3cc07f74
Safety of Treatment of Uterine Fibroids With Asoprisnil [clinicaltrials:NCT00156208]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Long Term Safety Throughout 18 month treatment period [clinicaltrials_resource:ffd55f1aa78e0a130612e1bd3cc07f74]

10mg Tablet, oral Daily for 18 months
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ffd55f1aa78e0a130612e1bd3cc07f74
Bio2RDF identifier
ffd55f1aa78e0a130612e1bd3cc07f74
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ffd55f1aa78e0a130612e1bd3cc07f74
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
Throughout 18 month treatment period
description
10mg Tablet, oral Daily for 18 months
identifier
clinicaltrials_resource:ffd55f1aa78e0a130612e1bd3cc07f74
title
Long Term Safety Throughout 18 month treatment period
@en
inDataset
type
label
Long Term Safety Throughout 18 ...... 55f1aa78e0a130612e1bd3cc07f74]
@en